Literature DB >> 30223971

Management of Venous Sinus Thrombosis.

Nicholas Sader1, Madeleine de Lotbinière-Bassett1, Michael K Tso1, Mark Hamilton2.   

Abstract

Cerebral venous sinus thrombosis (CVST) is a rare subtype of cerebrovascular disease representing 0.5% of strokes. The signs and symptoms of CVST are often nonspecific, and variable in duration, with the common results being delayed diagnosis and treatment. Increased awareness in the medical community and advancements in imaging modalities have produced faster diagnosis with improved patient outcomes. The preferred initial treatment is with a low molecular weight heparin. After the acute stage of CVST, treatment with a vitamin K antagonist (oral anticoagulant therapy) is recommended. Current evidence suggests that in the future, factor Xa inhibitor drugs may be used for long-term therapy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticoagulation; Cerebral thrombosis; Cerebral venous sinus thrombosis; Heparin; Low molecular weight heparin; Sinus thrombosis; Venous stroke

Mesh:

Substances:

Year:  2018        PMID: 30223971     DOI: 10.1016/j.nec.2018.06.011

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  3 in total

1.  Cerebral Venous Thrombosis at High Altitude: A Retrospective Cohort of Twenty-one Consecutive Patients.

Authors:  Nicolas K Khattar; Fitri Sumardi; Ajmal Zemmar; Quinghua Liang; Haiyang Li; Yazhou Xing; Hugo Andrade-Barazarte; Jack L Fleming; Iype Cherian; Juha Hernesniemi; Joseph S Neimat; Robert F James; Sunil Munakomi; Dale Ding
Journal:  Cureus       Date:  2019-06-19

2.  Frequency and characteristics of the JAK2 V617F mutation in 23 cerebral venous sinus thrombosis patients with thrombocytosis.

Authors:  Qiang Ma
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

3.  Cerebral venous thrombosis of the sphenoparietal sinus: A case report.

Authors:  Camille K Milton; David L Gordon; Chad A Glenn; Andrew K Conner
Journal:  Surg Neurol Int       Date:  2021-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.